Placebo concept defined correctly by 45.9% of OTC label comprehension study subjects.
This article was originally published in The Tan Sheet
Executive Summary
PLACEBO CONCEPT MISDEFINED/UNDEFINED BY OVER HALF OF STUDY POPULATION in a 440-subject, multi-site mall-intercept study on OTC label comprehension coordinated by Indianapolis, Ind.-based Walker Information. "Only 45.9%" of consumers interviewed "could correctly define the term `placebo,'" Walker Information VP-Business Development Susan Shellabarger reported at an Oct. 28-29 meeting of the Regulatory Affairs Professional Society in Washington, D.C. The study will appear in a future issue of the Drug Information Association's Drug Information Journal.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC